期刊
ONCOTARGET
卷 7, 期 33, 页码 52631-52642出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.10616
关键词
cell proliferation; Drosophila; cell competition; cancer
资金
- Spanish Ministry of Economy (BFU) [2009-12410, 2012-38191]
- CNIO
- European Research Council (Advanced ERC Grant)
- Framework Program 7 of the European Union (RISK-IR)
- Spanish Ministry of Economy (SAF)
- Regional Government of Madrid
- Botin foundation
- Ramon Areces foundation
- AXA foundation
- Ramon y Cajal program
Human tumors of various tissue origins show an intriguing over-expression of genes not considered oncogenes, such as that encoding Troponin-I ( TnI), a well-known muscle protein. Out of the three TnI genes known in humans, the slow form, TNNI1, is affected the most. Drosophila has only one TnI gene, wupA. Here, we studied excess-and loss-of function of wupA in Drosophila, and assayed TNNI1 down regulation in human tumors growing in mice. Drosophila TnI excess-of-function increases proliferation and potentiates oncogenic mutations in Ras, Notch and Lgl genes. By contrast, TnI loss-of-function reduces proliferation and antagonizes the overgrowth due to these oncogenic mutations. Troponin-I defective cells undergo Flower-and Sparc-dependent cell competition. TnI can localize to the nucleus and its excess elicits transcriptional up-regulation of InR, Rap1 and Dilp8, which is consistent with the increased cell proliferation. Human tumor cell lines treated with a human Troponin-I peptide arrest in G(0)/G(1). In addition, proliferation of non-small-cell lung carcinoma xenografts in mice is restrained by TNNI1 down-regulation. Thus, Troponin-I reveals a novel function in cell proliferation that may be of therapeutic interest in certain types of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据